Status:
COMPLETED
Efficacy, Safety of T2769 in Dry Eye Disease
Lead Sponsor:
Laboratoires Thea
Conditions:
Dry Eye Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Efficacy of T2769 in Dry Eye Desease
Detailed Description
Multicenter and open study
Eligibility Criteria
Inclusion
- Signed and dated informed consent
- Male or female aged from ≥ 18 years old
- Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to study screening
Exclusion
- Best far corrected visual acuity ≤ 2/10
- Severe blepharitis Severe dry eye
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 18 2019
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03830359
Start Date
September 1 2018
End Date
February 18 2019
Last Update
March 16 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Universitaire Tahar Sfar
Mahdia, Tunisia, 5100
2
"Hôpital Universitaire Fattouma Bourguiba
Monastir, Tunisia, 5000
3
"Hôpital de Forces de Sécurité Intérieure La Marsa
Tunis, Tunisia